APA (7th ed.) Citation

Stohs, E. J., Alexander, B. T., Fey, P. D., Foreman, M. C. L., Xu, L., Penewit, K., . . . Werth, B. J. (2026). Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil. Open Forum Infectious Diseases, 13(3), 1. https://doi.org/10.1093/ofid/ofag074

Chicago Style (17th ed.) Citation

Stohs, Erica J., Bryan T. Alexander, Paul D. Fey, Melanie C L. Foreman, Libin Xu, Kelsi Penewit, Adam Waalkes, Stephen J. Salipante, and Brian J. Werth. "Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil." Open Forum Infectious Diseases 13, no. 3 (2026): 1. https://doi.org/10.1093/ofid/ofag074.

MLA (9th ed.) Citation

Stohs, Erica J., et al. "Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil." Open Forum Infectious Diseases, vol. 13, no. 3, 2026, p. 1, https://doi.org/10.1093/ofid/ofag074.